AU1397495A - Diagnostic tests and reagents for detecting risk of alzheimer's disease and stroke - Google Patents
Diagnostic tests and reagents for detecting risk of alzheimer's disease and strokeInfo
- Publication number
- AU1397495A AU1397495A AU13974/95A AU1397495A AU1397495A AU 1397495 A AU1397495 A AU 1397495A AU 13974/95 A AU13974/95 A AU 13974/95A AU 1397495 A AU1397495 A AU 1397495A AU 1397495 A AU1397495 A AU 1397495A
- Authority
- AU
- Australia
- Prior art keywords
- alzheimer
- reagents
- stroke
- disease
- diagnostic tests
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16624193A | 1993-12-13 | 1993-12-13 | |
| US166241 | 1993-12-13 | ||
| US24551094A | 1994-05-18 | 1994-05-18 | |
| US245510 | 1994-05-18 | ||
| PCT/US1994/013841 WO1995016787A1 (en) | 1993-12-13 | 1994-11-16 | Diagnostic tests and reagents for detecting risk of alzheimer's disease and stroke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1397495A true AU1397495A (en) | 1995-07-03 |
Family
ID=26862095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU13974/95A Abandoned AU1397495A (en) | 1993-12-13 | 1994-11-16 | Diagnostic tests and reagents for detecting risk of alzheimer's disease and stroke |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1397495A (en) |
| WO (1) | WO1995016787A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
| AU2006319358B2 (en) | 2005-11-30 | 2012-01-19 | AbbVie Deutschland GmbH & Co. KG | Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
| KR20140087058A (en) | 2005-11-30 | 2014-07-08 | 애브비 인코포레이티드 | Monoclonal antibodies against amyloid beta protein and uses thereof |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| CA2796339C (en) | 2010-04-15 | 2020-03-31 | Abbott Laboratories | Amyloid-beta binding proteins |
| JP6147665B2 (en) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | Amyloid beta-binding protein |
-
1994
- 1994-11-16 AU AU13974/95A patent/AU1397495A/en not_active Abandoned
- 1994-11-16 WO PCT/US1994/013841 patent/WO1995016787A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995016787A1 (en) | 1995-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5508798A (en) | Diagnostic and therapeutic reagents for alzheimer's disease | |
| AU3891499A (en) | Diagnostic tests for alzheimer's disease | |
| AU2991697A (en) | Methods of diagnosing clinical subtypes of crohn's disease | |
| NZ233109A (en) | Diagnosing alzheimer's disease using a beta-amyloid protein antibody | |
| AU2414092A (en) | Diagnostic method for alzheimer's disease | |
| IL105216A0 (en) | Method and kit for the diagnosis of alzheimer's disease | |
| GB9316727D0 (en) | Models of alzheimers's disease | |
| AU4744796A (en) | System and method for detection and quantification of parkinson's disease | |
| AU1742395A (en) | Methods of diagnosing ulcerative colitis and crohn's disease | |
| AU7556994A (en) | Methods for the diagnosis of alzheimer's disease | |
| AU1441988A (en) | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor | |
| IL122584A0 (en) | Diagnostic test meal and methods of use thereof | |
| AU6907496A (en) | Process for detecting pentosidine and for assessing the biological age of a biological sample | |
| DE69604228D1 (en) | Pupil measurement set-up and Alzheimer's disease diagnosis system | |
| AU4636993A (en) | Diagnosing alzheimer's disease and schizophrenia | |
| HUP0003684A3 (en) | Diagnostic test for alzheimer's disease | |
| AU1397495A (en) | Diagnostic tests and reagents for detecting risk of alzheimer's disease and stroke | |
| AU5153398A (en) | Diagnostic method for the detection of alzheimer's disease in living patients | |
| AU5068090A (en) | Endometriosis diagnosis methods and reagents | |
| EP0838027A4 (en) | DETECTION OF ANALYTES OF REDUCED DIMENSIONS | |
| GB9314011D0 (en) | New diagnostic assay for detection of syphilis | |
| AU7201696A (en) | Method of diagnosing crohn's disease | |
| AU4781193A (en) | Clinical test for detection of alzheimer's disease | |
| AU5157493A (en) | Protein specific for alzheimer's disease and method of diagnosing alzheimer's disease through detection of the protein | |
| AU4228193A (en) | Identification of brain alpha1-antichymotrypsin and methods for diagnosing disease based on its detection |